Home Healthcare Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global Home Healthcare Market Trends and Insights

Aging Populations Driving Chronic-Care Demand

The World Health Organization estimates that 1.4 billion people will be aged 60 plus by 2030, with 80% residing in low- and middle-income nations where institutional long-term care remains limited. Each added year of life expectancy beyond 75 correlates with three to five additional years of chronic-disease management that is less costly when delivered at home than in skilled-nursing facilities. Japan already spends heavily on community-based integrated care under its long-term care insurance scheme, providing a template for other super-aged societies. In China, the 14th Five-Year Plan mandates a 15-minute radius for elderly community services in urban areas, driving local demand for portable diagnostics and telemedicine that link township clinics to tertiary centers. As similar demographic pivots unfold across Europe and North America, the home healthcare market benefits directly from scaled, policy-backed patient migration out of acute settings.

Reimbursement Expansion for Remote Monitoring

The Centers for Medicare & Medicaid Services permanently added CPT codes 99453, 99454, 99457, and 99458, reimbursing providers for device setup, data transmission, and monthly physiologic review, thus normalizing remote-patient monitoring across urban and rural settings alike^{[1]“Calendar Year 2025 Medicare Physician Fee Schedule Final Rule,” Centers for Medicare & Medicaid Services, cms.gov}. Commercial insurers such as UnitedHealthcare and Humana now pay 85-90% of in-office rates for similar services, closing the margin gap that once hindered physician adoption. The shift converts hardware into a recurring revenue model whereby manufacturers subsidize devices and earn subscription fees, mirroring consumer-wearable economics yet underpinned by clinical-grade accuracy and FDA oversight.

AI-Enabled Devices Boost Proactive Home Care

Between 2024 and 2025, the FDA cleared eight algorithms embedded in home-use devices, including Apple Watch atrial fibrillation detection, Eko low-ejection-fraction screening, and Insulet’s Omnipod 5 for automated insulin delivery. Edge processors now let devices run inference locally, trimming latency from seconds to milliseconds and addressing privacy concerns inherent in cloud transmissions. Early results are compelling: ResMed’s Smart Comfort AI cut apnea events and raised therapy adherence by 18 percentage points after its December 2025 clearance.

Shift to Hospital-at-Home Models

CMS’s Acute Hospital Care at Home waiver allows more than 300 hospitals to bill full DRG rates for services delivered in residences, producing 20% lower 30-day readmissions and higher patient satisfaction than traditional admissions. The United Kingdom’s National Health Service similarly targets a 15% reduction in emergency-department crowding through virtual wards that monitor 10,000 concurrent patients. The model blurs equipment and service boundaries, pressuring standalone agencies to integrate vertically or accept subcontractor status.

Shortage of Skilled Home-Care Clinicians

The United States faces a projected 78,000-nurse deficit by 2025, and home-health-aide turnover tops 65% in several states, limiting agencies’ capacity to accept new patients even as demand rises. Median aide pay of USD 13.50 per hour lags other service sectors, forcing agencies to raise wages 12-18% since 2024, compressing margins that averaged 3-5% pre-pandemic.

Cyber-Security & Privacy Threats to Medical IoT

In 2024 the FDA required software bills of materials and vulnerability management plans for all networked devices after researchers cataloged 127 exploitable flaws across common insulin pumps and glucose monitors^{[2]“Cybersecurity in Medical Devices,” U.S. Food and Drug Administration, fda.gov}. HIPAA penalties reach USD 1.5 million per breach, pushing smaller manufacturers toward partnerships or exits as compliance costs consume up to 12% of R&D budgets.

Segment Analysis

By Healthcare Type: Equipment Anchors Revenue, Software Accelerates

Equipment represented 48.55% of the home healthcare market in 2025, spotlighting the capital intensity of therapeutic gear such as ventilators, dialysis systems, and insulin pumps. Therapeutic equipment revenues gain from Medicare’s policy that reimburses home dialysis at 80-90% of in-center rates, enlarging the home healthcare market size for renal-care technology by routing high-acuity procedures into domestic environments. Diagnostic and monitoring devices become more affordable; fingerstick glucometer average selling prices fell 25% between 2023 and 2025 as continuous glucose monitors captured share, compressing margins for legacy products. Mobility assist equipment faces direct-to-consumer pressure that widens geographic reach but thins distributor profits.

Services constitute the second-largest 2025 slice, yet staffing deficits force agencies to triage high-acuity cases while technology offsets some labor gaps through remote vitals monitoring and tele-therapy. Hospice and palliative care expand steadily as Medicare’s hospice benefit lowers financial barriers, and tele-homecare volumes stay elevated under permanent billing codes. Software platforms, though starting from a smaller base, are forecast to post a 12.25% CAGR through 2031 as electronic visit verification and open FHIR APIs become prerequisites for payer contracts. The FDA’s Software as a Medical Device framework adds regulatory hurdles yet confers clinical credibility that hastens commercial adoption.

Note: Segment shares of all individual segments available upon report purchase

By Indication: Cardiovascular Leads, Diabetes Surges

Cardiovascular conditions held 26.53% of home healthcare market share in 2025, aided by validated home blood-pressure cuffs, implantable loop recorders, and AI-enabled electrocardiogram patches that let clinicians titrate therapy remotely. Remote heart-failure monitoring programs reduce 30-day readmissions by up to 30%, making value-based bundles financially attractive for insurers. Meanwhile, diabetes is on track for a 10.85% CAGR, the fastest among tracked indications, thanks to continuous glucose monitors and closed-loop pumps whose mean absolute relative differences now sit below 10%, meeting replacement thresholds for fingerstick calibration. The FDA’s 2025 clearance of Omnipod 5 for Type 2 diabetes enlarged the addressable user base by an order of magnitude, intensifying competition among pump manufacturers.

Respiratory disorders, including sleep apnea, gain from cloud-connected CPAP machines that upload adherence data to satisfy Medicare’s usage rules, while oncology infusion at home reduces hospital facility fees by 40-60% and limits immunocompromised patients’ exposure to pathogens. Wound-care revenue grows with rental models for negative-pressure systems, and neurology is emerging as smartphone-based digital therapeutics prove effective as adjuncts to physical therapy.

Geography Analysis

North America commanded 42.13% of 2025 revenue, powered by 52% Medicare Advantage penetration and CMS waivers that reimburse inpatient-level services rendered at home. Yet clinician shortages constrain capacity: certified-aide turnover exceeds 65%, and agencies often cap referrals, slowing potential expansion despite payer demand. Canada’s funding for home care remains under 4% of total health expenditure, and Mexico’s telemedicine pilots are creating incremental device demand as coverage extends into rural states.

Asia-Pacific is forecast to lead growth at 9.51% CAGR through 2031, propelled by Japan’s super-aged demographic profile and Kaigo Hoken reforms that fund comprehensive in-home services^{[3]“Long-Term Care Insurance System,” Ministry of Health, Labour and Welfare, Japan, mhlw.go.jp}. China mandates proximal community care, while India’s Production Linked Incentive scheme subsidizes local device manufacturing, slicing retail prices for basic monitors by up to 30%. South Korea and Australia experiment with outcome-tied payment models that reward agencies for avoiding readmissions rather than maximizing visit counts.

Europe sustains meaningful share, with the United Kingdom’s virtual wards and Germany’s fast-track reimbursements for digital therapeutics broadening access. France’s hospitalisation à domicile handled 120,000 patients in 2024, predominantly for intravenous antibiotics and chemotherapy, underscoring the region’s advanced policy backing. Italy and Spain offer limited public reimbursement, producing a two-tier landscape in which affluent households fund private care while others rely on informal caregivers.

Smaller yet accelerating markets include the Gulf Cooperation Council states, which invest sovereign capital into smart-home monitoring, and South Africa, where private insurers pilot remote monitoring for HIV adherence. Brazil’s Programa Melhor em Casa treated 200,000 patients in 2024 but remains unevenly distributed, indicating latent demand for devices and software in underserved northern regions.